Brief: HLS Says Private Payer Health Plan Coverage In Canada For Vascepa Expected To Reach Over 80% By Feb. End
Feb 16 (Reuters) - HLS Therapeutics Inc HLS.TO :
* HLS THERAPEUTICS INC - PRIVATE PAYER HEALTH PLAN COVERAGE
IN
CANADA FOR VASCEPA IS EXPECTED TO REACH MORE THAN 80% BY END OF
FEBRUARY 2021
Source text for Eikon: ID:nCNW6X6RZa
Further company coverage: HLS.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on HLS Therapeutics
See all newsBrief: Hls Therapeutics Increases Normal Course Issuer Bid
Brief: HLS Therapeutics Announces Q2 2026 Financial Results
Canada's HLS Therapeutics Q2 revenue rises on higher cardiovascular drugs demand
Brief: HLS Therapeutics - Secures Nilemdo Reimbursement With Private Payers Covering 80% Of Privately Insured Canadians
Canada Research Roundup: CIBC ,HLS Therapeutics, TD Bank Group